Confo Therapeutics (Public limited company)
Confo Therapeutics is a Belgian company registered with the Crossroads Bank for Enterprises under enterprise number 0632.474.939. It was founded on 11-06-2015. Its registered office is in Ghent. Its main activity is: Scientific research and development. Its annual accounts for 2025 report equity of € 33 287 463 and a loss of € 17 407 050. These accounts report 59 full-time equivalents. Addrly gives it a financial health grade of A, on a scale from A (safest) to E (most at risk). It filed its annual accounts within the legal deadline for each of its last 4 financial years.
Information last updated on 10-10-2026.
Company information
Key figures of Confo Therapeutics
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
Profit / lossiWhat the period earned after taxes. A negative amount is a loss. | € -17 407 050-54 % | € -11 335 378 | € 31 130 363 | € -15 585 554 |
EquityiWhat belongs to the shareholders: capital contributed, reserves and profits kept in the company. | € 33 287 463-34 % | € 50 633 033+115 % | € 23 569 858 | € -7 560 505 |
Total assetsiEverything the company owns. Equal to total equity and liabilities, which says how it is financed. | € 37 770 554-31 % | € 54 783 961+25 % | € 43 957 014+225 % | € 13 540 913 |
Gross marginiSales and other operating income, minus purchases of goods and services. What is left to pay the staff and everything else. | - | - | - | - |
Employees (FTE)iAverage number of workers over the period, in full-time equivalents. | 59+13 % | 52+13 % | 45.9-21 % | 58.1 |
Financial estimate
- 15 Shareholders
- 2 Board links
Similar companies
Other companies in the same activity in Ghent.
| Company | Town |
|---|---|
| BASF Agricultural Solutions Belgium | 9052 Gent |
| VLAAMS INSTITUUT VOOR BIOTECHNOLOGIE - FLANDERS INSTITUTE FOR BIOTECHNOLOGY | 9052 Gent |
| VIXEN BIOSYSTEMS | 9052 Gent |
| FUJIREBIO EUROPE | 9052 Gent |
| DEVGEN | 9052 Gent |
| Eurofins Amatsigroup | 9052 Gent |
| ABLYNX | 9052 Gent |
| BIOMEDICAL APPLICATION OF RESEARCH IN INFECTIOUS DISEASES CONTROL | 9052 Gent |
Frequently asked questions
Is Confo Therapeutics still active? Yes. The Crossroads Bank for Enterprises lists Confo Therapeutics as active.
What is the VAT number of Confo Therapeutics? The VAT number of Confo Therapeutics is BE 0632.474.939.
When was Confo Therapeutics founded? Confo Therapeutics was founded on 11-06-2015.
What is the address of Confo Therapeutics? The current registered office of Confo Therapeutics is Technologiepark-Zwijnaarde 30, 9052 Gand.
When did Confo Therapeutics last file annual accounts? The latest annual accounts of Confo Therapeutics were filed on 08-06-2026.
Does Confo Therapeutics file its annual accounts on time? Yes. Confo Therapeutics filed its annual accounts within the legal deadline for each of its last 4 financial years.
How many employees does Confo Therapeutics have? Confo Therapeutics employs 59 full-time equivalents according to its most recent annual accounts.
Is Confo Therapeutics financially healthy? Addrly gives Confo Therapeutics a financial health grade of A, on a scale from A (safest) to E (most at risk). The failure probability and the indicators behind it are visible with a free account.
Is Confo Therapeutics profitable? The annual accounts of Confo Therapeutics for 2025 show a loss of € 17 407 050.
What is the equity of Confo Therapeutics? The equity of Confo Therapeutics was € 33 287 463 at the close of the 2025 financial year.
Who are the directors of Confo Therapeutics? The annual accounts of Confo Therapeutics record 12 mandates. The names, roles and dates are visible with a free account.
Can Confo Therapeutics receive Peppol e-invoices? Yes. Confo Therapeutics is registered on the Peppol network and can receive structured electronic invoices.
What does Confo Therapeutics do? The main activity of Confo Therapeutics is: Scientific research and development.